HEPATIC ERYTHROPOIETIN SYNTHESIS IS ENHANCED IN HEMODIALYSIS PATIENTS WHO DO NOT REQUIRE ERYTHROPOIESIS-STIMULATING AGENTS

被引：0
|
作者：
Hirayama, Aki [1 ]
Yanagawa, Takamoto [2 ]
Kaneko, Yoko [2 ]
Nagano, Yumiko [1 ]
Owada, Shigeru [3 ]
Ishizu, Takashi [2 ]
机构：
[1] Tsukuba Univ Technol, Ctr Integrar Med, Tsukuba, Ibaraki, Japan
[2] Tsukuba Cent Hosp, Dept Nephrol, Ushiku, Japan
[3] Asa Clin, Kawasaki, Kanagawa, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0847
引用
收藏
页码：1178 / 1178
页数：1
相关论文
共 50 条
  • [31] ERYTHROPOIESIS-STIMULATING AGENTS AND THROMBOTIC EVENTS IN DIALYSIS PATIENTS
    Suttorp, Marit M.
    Hoekstra, Tiny
    Ocak, Gurbey
    Van Diepen, Anouk T. N.
    Ott, Ilka
    Mittelman, Moshe
    Rabelink, Ton J.
    Krediet, Raymond T.
    Dekker, Friedo W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 233 - 233
  • [32] Erythropoiesis-stimulating agents and thrombotic events in dialysis patients
    Suttorp, Marit M.
    Hoekstra, Tiny
    Ocak, Gurbey
    van Diepen, Anouk T. N.
    Ott, Ilka
    Mittelman, Moshe
    Rabelink, Ton J.
    Krediet, Raymond T.
    Dekker, Friedo W.
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1081 - 1086
  • [33] Use and cost of erythropoiesis-stimulating agents in patients with cancer
    Daniel, Gregory
    Hurley, Dana
    Whyte, Joanna L.
    Willey, Vincent
    Wilson, Marcus
    Kallich, Joel
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (07) : 1775 - 1784
  • [34] Erythropoiesis-stimulating agents in congestive heart failure patients
    Robles Perez-Monteoliva, Nicolas Roberto
    Macias Nunez, Juan Francisco
    Perez de Villar, Julio Herrera
    MEDICINA CLINICA, 2014, 142 (05): : 215 - 218
  • [35] Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
    Haase, Volker H.
    Chertow, Glenn M.
    Block, Geoffrey A.
    Pergola, Pablo E.
    deGoma, Emil M.
    Khawaja, Zeeshan
    Sharma, Amit
    Maroni, Bradley J.
    McCullough, Peter A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (01) : 90 - 99
  • [36] Examining the Magnitude of Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients
    Weinhandl, Eric D.
    Hwang, Yunji
    Gilbertson, David T.
    Petersen, Jeffrey
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 247 - 247
  • [37] Mortality Associated with Dose Response of Erythropoiesis-Stimulating Agents in Hemodialysis versus Peritoneal Dialysis Patients
    Duong, Uyen
    Kalantar-Zadeh, Kamyar
    Molnar, Miklos Z.
    Zaritsky, Joshua J.
    Teitelbaum, Isaac
    Kovesdy, Csaba P.
    Mehrotra, Rajnish
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 35 (02) : 198 - 208
  • [38] Can a single inflammatory marker adequately predict resistance to erythropoiesis-stimulating agents in hemodialysis patients?
    Eleftheriadis, Theodoros
    Antoniadi, Georgia
    Liakopoulos, Vassilios
    Stefanidis, Ioannis
    HEMODIALYSIS INTERNATIONAL, 2013, 17 (01) : 130 - 131
  • [39] RESISTANCE TO ERYTHROPOIESIS-STIMULATING AGENTS MAY BE ASSOCIATED WITH ARETRIAL MICRO-CALCIFICATION IN HEMODIALYSIS PATIENTS
    Jin, Choi Su
    Soo, Kim Young
    Ae, Yoon Sun
    Ok, Kim Young
    NEPHROLOGY, 2014, 19 : 181 - 181
  • [40] Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study
    Rostoker, Guy
    Griuncelli, Mireille
    Loridon, Christelle
    Couprie, Renaud
    Benmaadi, Abbes
    Bounhiol, Catherine
    Roy, Myriam
    Machado, Gabrielle
    Janklewicz, Phillippe
    Drahi, Gilles
    Dahan, Herve
    Cohen, Yves
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (10) : 991 - +
12345